Found 8 matching trials
RespimatĀ® Inhaler vs a Metered Dose Inhaler Using BerodualĀ® in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 Study to compare the lung and oropharyngeal deposition of BerodualĀ® (fenote...
Show More Location
Multiple Locations
Learn More & Join Trial
Postmarketing Surveillance Study of BerodualĀ® Metered-dose Inhaler in Chronic Obstructive Airways Disease N/A The aim of this postmarketing surveillance is to obtain further information...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma PHASE3 Study to demonstrate that at least one of the two doses of Berodual® (50 µg...
Show More Location
Multiple Locations
Learn More & Join Trial
BerodualĀ® RespimatĀ® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease PHASE3 Study to compare the effect of 'natural' as opposed to 'optimal' technique ...
Show More Location
Multiple Locations
Learn More & Join Trial
Post-marketing Surveillance of BerodualĀ® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease N/A The aim of this post-marketing surveillance is to obtain further informatio...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 To demonstrate that at least one of the two doses of Berodual® (50 µg fenot...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients PHASE3 Study to demonstrate that at least one of the two doses of Berodual® (50 µg...
Show More Location
Multiple Locations
Learn More & Join Trial
Postmarketing Surveillance Study of BerodualĀ® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease N/A The aim of this postmarketing surveillance is to obtain further information...
Show More Location
Multiple Locations
Learn More & Join Trial